DRUG BetaShares Global Healthcare Currency Hedged ETF

$9.31+2.2%
Compare DRUG with another fund →

BetaShares Global Healthcare Currency Hedged ETF is a sector & thematic ETF from BetaShares — 66 holdings, with $163.0m under management. 98% of its money is in health care. Its two largest holdings, ELI LILLY & CO and JOHNSON & JOHNSON, make up 17% of the fund. It charges 0.57% a year.

the last 3 months

$10,000 in DRUG rose to $10,220.

No payout is counted in this period.

+2.20% by price

▲ ①30 Oct · What added the most

One company added the most: Eli Lilly

Eli Lilly added +$80 on every $10,000. Its share price rose 7.1% over the period, in its own currency. On average $817 of every $10,000 in DRUG was in Eli Lilly.

What moved it

The other 58together+$167
All companies together+$279

What held it back least

No sector took money away

Health Care added the least: +$279 on every $10,000.

Where they are

The companies by country

On $10,000 at the start

$10,000 at the start
Touch the line for a date and price
Start
$10,000
End
$10,220
High
$11,021
Low
$9,528

High and low were 14% apart.

How it adds up, on $10,000

Pricewhat the price did+$220

What you own

Of every $10,000 in DRUG

  • Eli Lilly$817
  • J&J$802
  • AbbVie$673
  • The other 61$7,708

The news · estimated

What the news did

Results above what was expected added +$139; results below what was expected took $72 on $10,000.

Results above what was expected+$13910 companiesBiggest: Eli Lilly, 30 Oct, +$57
Results below what was expected−$726 companiesBiggest: J&J, 14 Oct, −$46

Other news

Days with no flagged newsEvery other day: moves too small to flag+$249

How is the site working for you?